Evidence map›Paper›PMID 26948660›Full record

ArticleAmino acids2016

Proteomic profiling identifies the inorganic pyrophosphatase (PPA1) protein as a potential biomarker of metastasis in laryngeal squamous cell carcinoma.

Magdalena Bodnar, Magdalena Luczak, Kinga Bednarek, Lukasz Szylberg, Andrzej Marszalek, Reidar Grenman, Krzysztof Szyfter, Malgorzata Jarmuz-Szymczak, Maciej Giefing

Open access · hybridAbstract read
In one paragraph

Article in Amino acids, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Relationship betweenMediators of inflammation · 2019
    Article
  10. Article
  11. Article
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 7 institutions in 2 countries.

Magdalena BodnarDepartment of Clinical Pathomorphology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Bydgoszcz, Poland.
Magdalena LuczakInstitute of Bioorganic Chemistry, Polish Academy of Sciences, Poznan, Poland.
Kinga BednarekDepartment of Cancer Genetics, Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
Lukasz SzylbergDepartment of Clinical Pathomorphology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Bydgoszcz, Poland.
Andrzej MarszalekDepartment of Clinical Pathomorphology, Collegium Medicum in Bydgoszcz, Nicolaus Copernicus University in Torun, Bydgoszcz, Poland.
Reidar GrenmanDepartment of Otorhinolaryngology, Head and Neck Surgery, Turku University Hospital and University of Turku, Turku, Finland.
Krzysztof SzyfterDepartment of Cancer Genetics, Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
Malgorzata Jarmuz-SzymczakDepartment of Cancer Genetics, Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland.
Maciej GiefingDepartment of Cancer Genetics, Institute of Human Genetics, Polish Academy of Sciences, Poznan, Poland. giefingm@man.poznan.pl.
Institute of Human Genetics · PLCollegium Medicum in Bydgoszcz · PLGreater Poland Cancer Center · PLNicolaus Copernicus University · PLPoznan University of Medical Sciences · PLPoznań University of Technology · PLTurku University Hospital · FI

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Relapse and metastasis are the main causes of unfavorable outcome in head and neck cancers. Whereas, understanding of the molecular background of these processes is far from being complete. Therefore, in this study we aimed to identify potential biomarker candidates of relapse and metastasis in laryngeal squamous cell carcinoma (LSCC) by combining the 2D electrophoresis based protein screen and immunohistochemical analysis of candidate proteins. We screened three groups of LSCC cell lines derived from primary tumors, recurrent tumors and metastases and identified seven proteins that differed significantly in relative abundance between the analyzed groups. Among the identified proteins were the heat shock proteins HSP60 and HSP70 that were significantly downregulated both in recurrences- and metastases-derived cell lines but not in primary tumor-derived cell lines. Moreover, we identified significant upregulation of the annexin V, calreticulin and the inorganic pyrophosphatase (PPA1) exclusively in the metastases-derived cell lines. As these upregulated proteins could potentially become novel biomarkers of metastasis, we have compared their abundance in primary tumor LSCC N(0) cases, primary tumor LSCC N(+) cases as well as in LSCC metastases N(+). Our results show an intense increase of cytoplasmic PPA1 abundance in the N(+) (p = 0.000042) compared to the N(0) group. In summary, we show a group of proteins deregulated in recurrences and metastases of LSCC. Moreover, we suggest the PPA1 protein as a potential new biomarker for metastasis in this cancer.

Indexed as

ProteomicsAdultAgedBiomarkers, TumorCarcinoma, Squamous CellCell Line, TumorFemaleHumansInorganic PyrophosphataseLaryngeal NeoplasmsMaleMiddle AgedNeoplasm MetastasisNeoplasm ProteinsBiomarkers, TumorInorganic PyrophosphataseNeoplasm ProteinsBiomarkerLaryngeal cancerLSCCMetastasisPPA1

Identifiers

PMID26948660
PMCPMC4875942
OpenAlexW2296116262

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.